Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucagon secretion by transplanted alpha cells refers to the functional capacity of transplanted pancreatic alpha cells, often derived from human embryonic stem cells (hES), to secrete glucagon in response to physiological stimuli. This process is crucial for maintaining blood glucose levels, particularly during hypoglycemia, by stimulating hepatic glucose production. The transplanted cells must respond appropriately to glucose and other regulators of glucagon secretion to effectively restore glucose homeostasis. This target represents a promising avenue for restoring glycemic control where endogenous alpha cell function is lost or impaired.
Not applicable; cellular function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucagon Secretion by Transplanted Alpha Cells.